Insider Shareholders with Direct Ownership of En V Veno Medical Corp (NVNO)
This section provides a comprehensive overview of the insiders with direct ownership of En V Veno Medical Corp (NVNO). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
enVVeno Medical Corp Insider List
Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
---|---|---|---|---|---|
0 | 1,950,000 | 1,405,433 $4.51 Million | 27 |
Aug 21, 2020
Reduced 5.07%
|
|
Robert Andrew Berman
Chief Executive Officer |
221,500 | 0 | 222,236 $713,377 | 6 |
Dec 19, 2024
Added 5.12%
|
Francis Duhay
Director |
98,676 | 0 | 102,344 $328,524 | 3 |
Dec 31, 2024
Added 44.31%
|
Marc H. Glickman
SVP & Chief Medical Officer |
101,600 | 0 | 101,600 $326,136 | 2 |
Nov 30, 2021
Added 49.6%
|
Craig Glynn
Chief Financial Officer |
50,000 | 0 | 50,000 $160,500 | 1 |
Nov 30, 2021
Added 50.0%
|
Matthew Jenusaitis
Director |
75,503 | 0 | 16,545 $53,109 | 5 |
Dec 19, 2024
Added 36.77%
|
Robert Gray
Director |
7,583 | 0 | 11,155 $35,807 | 4 |
Dec 31, 2024
Added 23.88%
|
Sanjay Shrivastava
Director |
6,788 | 0 | 9,288 $29,814 | 3 |
Dec 24, 2024
Added 36.76%
|
Hamed Alavi
Chief Technology Officer |
8,334 | 8,334 | 0 $0 | 2 |
Mar 13, 2024
Reduced 100.0%
|